General Medicine has raised a $120 million Series B as it builds a consumer storefront for healthcare. Instead of sending a patient from a medical answer into a fresh search for a provider, price and appointment, the product keeps medical history and clinical guidance alongside the steps for obtaining the recommended care. Andreessen Horowitz led the round.

The inventory behind that storefront spans more than 2,900 products and services, including medications, laboratory work, imaging, specialist consultations and selected in-person visits and procedures. A patient can begin with a specific need, see the cost tied to current insurance coverage and get help reaching the appropriate service.

General Medicine combines its own medical group with a marketplace of outside primary-care physicians and specialists. That structure lets the storefront connect patients with more services than one practice could provide while retaining their history, medications and insurance information. Someone who first arrives for a prescription refill can return later for laboratory work or a specialist opinion without starting over.

The product addresses the work between knowing what care may be needed and actually receiving it. In a conventional journey, records, coverage checks, referrals, authorizations, scheduling and prices may sit with different organizations. General Medicine’s bet is that keeping the patient’s information and next steps together can make each later interaction build on the earlier ones.

Direct consumers are the company’s current market. General Medicine is also building an enterprise offering that would let health systems, insurers and pharmacies provide the same guidance, pricing and access infrastructure to their patients or members. Andreessen Horowitz’s announcement describes that enterprise product as under development.

Sources
1Andreessen Horowitz — Investing in General Medicine ↗